Skip to main content
. Author manuscript; available in PMC: 2019 Feb 8.
Published in final edited form as: NeuroRehabilitation. 2017;40(4):501–508. doi: 10.3233/NRE-171437

Fig. 1.

Fig. 1.

Relative mRNA Expression of ARG1, LY96, MMP9, s100a12, and CCR7 in TBI Compared to Control. Relative mRNA expression of ARG1, LY96, MMP9, s100a12 was significantly increased in peripheral blood of TBI patients within 24 hours of injury compared to control subjects. The mean fold changes for ARG1, LY96, MMP9, s100a12 were 11, 1.2, 1.9, and 7.8, respectively. There was a 2.6 fold decreased in relative CCR7 mRNA expression in TBI compared to control. Gray bars represent control subjects and black bars represent TBI patients. Data is expressed as fold change±SD, and the dotted line at Fold Change = 1 is a reference to the control group. ** represents significance at p < 0.001, * represents significance at p < 0.05.